![Samantha Willing](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Samantha Willing worked at Neoleukin Therapeutics, Inc. from 2019 to 2022 as Vice President-People.
In 2024, worked at LeonaBio, Inc. as Chief People Officer.
Completed undergraduate education at Washington State University.
| Sociétés | Poste | Fin |
|---|---|---|
| LEONABIO, INC. | Responsable des Ressources Humaines | 10/10/2024 |
| NEUROGENE INC. | Responsable des Ressources Humaines | 01/08/2022 |
Actives
Inactives
Sociétés cotées
Entreprise privées
| Entreprise privées | 3 |
|---|---|
LeonaBio, Inc.
 LeonaBio, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company | Health Technology |
Washington State University
 Washington State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Neoleukin Therapeutics, Inc.
 Neoleukin Therapeutics, Inc. BiotechnologyHealth Technology Develops de novo – therapeutic proteins to treat serious immunological disorders, including cancer and autoimmunity | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national
